Share
654 Posts.
lightbulb Created with Sketch. 59
clock Created with Sketch. 08/01/20
19:58
Share
Originally posted by bedger:
↑
I thought you'd made the wrong decision to sell out over $0.50, but you were correct and brave to do so with a view to buying back in - personally I have been invested in this stock to a degree since its 2014 IPO and daren't sell out now on the verge of the ATI announcement (but understand many are sceptical of OCC's ATI timeline) and what I thought was solid Insto's interest in that. Volumes are thin and as you say small cap health selling across the board (MSB was +5% early and -3% in the afternoon). I too am bullish long-term on health care, or more precisely bio-tech. I am on MSB and PAR too. OCC is by far my favourite of the three. I am utterly convinced of the efficacy of CelGro and ATI as is obvious from my posts. I don't get how Insto's started to pick up on the stock late 2019 and have abandoned since the CR. Being anchored to $0.50 perhaps a $0.48-52 range for a few weeks would not have surprised me, but $0.45...
Expand
Just need to be patient Bedger. I'm positive it will be a winner for us in the long run. I just think everyone has expectations that things will happen faster than can be reasonably expected. Slow and steady wins the race and I'm happy with that.
(20min delay)